Most recently, the Beckley Foundation released Roadmaps to Regulation: MDMA, outlining proposals that should underpin all evidence-informed drug policy and practice. In 2016, to coincide with the introduction of the UK’s Psychoactive Substances Act, Amanda Feilding released “Roadmaps to Regulation: New Psychoactive Substances.” The report surveys the complex and unique world of NPS production and distribution and suggests a harm reductive model for the legal regulation of this vast array of substances. The NPS report is part of wider family of reports, “Roadmaps to Regulation: Cannabis, Psychedelics, MDMA and NPS“.
This report, written by over 30 experts across the world, is the most robust attempt to date to open discussion on the issue of coca/cocaine regulation. It does so from a comprehensive and multidisciplinary perspective, with leading names in the relevant fields. It is a pivotal point in the difficult, yet necessary, discussion on the regulation of stimulants.
The Beckley Foundation Latin America Chapter produced two influential reports for the region (Paths for Reform: Proposed Options for Alternative Drug Policies in Guatemala and Illicit Drug Markets and Dimensions of Violence in Guatemala), investigating current trends of drug-related violence and proposing options for alternative drug policies.
This report, led by Prof Stephen Pudney, investigated the economic consequences of a regulated cannabis market in the UK, indicating that it could be worth as much as £1.25bn a year to the government.
This ground-breaking report, led by Prof Robin Room, was the first to carefully document the ways in which the UN Conventions can be amended in order to allow signatory countries the freedom to choose and experiment with domestic policies best suited to their individual needs.
This report, published in February 2011, was a joint effort of the Inter-American Dialogue and the Beckley Foundation. To encourage debate on the issues of drug regulation and the search for alternative approaches, the Inter-American Dialogue launched its drug policy project in 2009. This report is one of the critical products of that initiative. It offers six proposals to set the stage for a thorough rethinking of the US and global approach toward illicit drugs.
2006 Amanda Feilding convened a team of the world’s leading drug policy analysts to form theBeckley Foundation’s Global Cannabis Commission. The Commission consisted of Professors Robin Room, Wayne Hall, Peter Reuter, Benedikt Fischer, and Simon Lenton. The Commission prepared an overview of the latest scientific evidence surrounding cannabis and the policies that control its use, and identified possible routes forward, including depenalisation, decriminalization, and a regulated legal market. They also discussed how individual countries might reform cannabis policies to suit their individual needs. The 2008 Report of the Global Cannabis Commission formed the basis for the book “Cannabis Policy: Moving Beyond Stalemate” which was jointly published with Oxford University Press in 2010 and a Spanish translation, titled “Políticas Sobre el Cannabis” published in 2014.
These reports are part of an illustrious and influential library: between 2004 and 2009, Amanda Feilding and Mike Trace co-directed what was then called the Beckley Foundation Drug Policy Programme (BFDPP) – a partnership between the Beckley Foundation and DrugScope (at the time UK’s leading independent centre of expertise on drugs). The BFDPP was conceived to be an initiative dedicated to providing a rigorous, independent review of the effectiveness of national and international drug policies. At the time, the BFDPP chaired the International Drug Policy Consortium (IDPC), a global network of NGOs and professional networks who work together to promote objective debate around national and international drug policies, and provide advice and support to governments in the search for effective policies and programmes. Dame Ruth Runciman (former Chair of the UK Mental Health Act Commission) noted that the Beckley Foundation Drug Policy Programme (BFDPP) was the first global initiative driven by the non-governmental sector that recognised the centrality of analysis of the evidence base to drafting effective drug policy development. As part of this programme, Amanda Feilding and Mike Trace commissioned, wrote or edited a series of reports and briefing papers that provided an overview and analysis of drug policy effectiveness around the world. Although these reports are now a few years old, they were highly influential, with much of the information and analysis they contain remaining as pertinent now as it was when they were originally published.
Convenor: Amanda Feilding. Authors: Karenza Moore, Hattie Wells, Amanda Feilding, 2019
Amanda Feilding (Coordinating Editor) and Nicola Singleton, with additional input from Alex Stevens, 2016
Robin Room, Benedikt Fisher, Wayne Hall, Simon Lenton, Peter Reuter, Diana Rossi, Raúl Alejandro Corda (Authors), Manuel Casals (Translator), Amanda Feilding, Thomas C Schelling (Contributors), 2014
Amanda Feilding, Project Director; Corina Giacomello, Field Researcher, 2013
Amanda Feilding, Project Director; Corina Giacomello, Field Researcher, 2013
Stephen Pudney, Emilia Del Bono, Mark Bryan, 2013
Edited by Robin Room; Contributions by Robin Room and Sarah Mackay, 2012
Peter Hakim, 2011
Professors Robin Room, Peter Reuter, Wayne Hall, Benedikt Fischer, and Simon Lenton, 2010
Christopher Hallam and Dave Bewley-Taylor, January 2010
Christopher Hallam, January 2010
Louisa Degenhardt, Christopher Hallam and Dave Bewley-Taylor, September 2009
Jean-Félix Savary, Chris Hallam and Dave Bewley-Taylor, May 2009
Dave Bewley-Taylor, Chris Hallam, Rob Allen, March 2009
Dave Bewley-Taylor, Alex Stevens, Pablo Dreyfus, January 2009
Dave Bewley-Taylor and Chris Hallam, October 2008
Beatriz Acevedo, with Dave Bewley-Taylor and Coletta Youngers, September 2008
David Otiashvili, Péter Sározi, Gábor L Somogyi, May 2008
Laura Wilson, Alex Stevens, 2008
Robin Room, Wayne Hall, Peter Reuter, Benedikt Fischer, and Simon Lenton. Convened by Amanda Feilding, 2008
Maureen Meyer with contributions from Coletta Youngers and Dave Bewley-Taylor, February 2008
Caitlin Hughes, Alex Stevens, December 2007
Maureen Meyer, with contributions from Coletta Youngers and Dave Bewley-Taylor, November 2007
Louisa Degenhardt, Carolyn Day, Wayne Hall, Dave R Bewley-Taylor, July 2007
Kate Dolan, Effat Merghati Khoei, Cinzia Brentari, Alex Stevens, June 2007
Mike Trace, Gábor Somogyi, Christopher Hallam, Dave Bewley-Taylor, January 2007
Dave Bewley-Taylor, Mike Trace, November 2006
Alex Stevens, Christopher Hallam, Mike Trace, September 2006
Marcus Roberts, Dave Bewley-Taylor, Mike Trace, July 2006
Neil Hunt, Simon Lenton, John Witton, April 2006
Dave Bewley-Taylor, Mike Trace, February 2006
Molly Charles, Dave Bewley-Taylor, Amanda Feilding, October 2005
Marcus Roberts, Dave Bewley-Taylor, Mike Trace, October 2005
Mike Trace, Diane Riley, Gerry Stimson, September 2005
Bijan Nissaramanesh, Mike Trace, Marcus Roberts, July 2005
Dave Bewley-Taylor, Mike Trace, Alex Stevens, June 2005
Alex Stevens, Mike Trace, Dave Bewley-Taylor, June 2005
Neil Hunt, Mike Trace, Dave Bewley-Taylor, February 2005
Laurence Allen, Mike Trace, Axel Klein, 2005
Marcus Roberts, Axel Klein, Mike Trace, January 2005
Marcus Roberts, Mike Trace, Axel Klein, December 2004
William Bush, Marcus Roberts, Mike Trace, August 2004
Marcus Roberts, Axel Klein, Mike Trace, August 2004
Marcus Roberts, Axel Klein, Mike Trace, July 2004
Axel Klein, Marcus Roberts, Mike Trace, May 2004
Mike Trace, Axel Klein, Marcus Roberts, May 2004
Marcus Roberts, Axel Klein, Mike Trace, May 2004
Psilocybin for Depression
Type of publication